{
    "2019-03-05": [
        [
            {
                "time": "2018-04-10",
                "original_text": "Eli Lilly to offer half-price version of insulin amid Trump’s pressure to lower drug prices",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "half-price",
                        "insulin",
                        "Trump",
                        "lower drug prices"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Lilly to Bring Half-Priced Version of Popular Humalog Insulin",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Half-Priced",
                        "Humalog",
                        "Insulin"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Eli Lilly will offer a half-off version of its popular insulin drug Humalog",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "half-off",
                        "Humalog",
                        "insulin"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-24",
                "original_text": "Lilly Receives FDA Priority Review Designation for Emgality® (galcanezumab-gnlm) Injection for the Preventive Treatment of Episodic Cluster Headache in Adults",
                "features": {
                    "keywords": [
                        "Lilly",
                        "FDA",
                        "Priority Review",
                        "Emgality",
                        "galcanezumab-gnlm",
                        "Cluster Headache"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Drugmaker Eli Lilly cutting price of popular insulin Humalog",
                "features": {
                    "keywords": [
                        "Drugmaker",
                        "Eli Lilly",
                        "cutting price",
                        "Humalog",
                        "insulin"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}